Park Square has placed Frederick Beddingfield III, M.D., Ph.D., as Chief Executive Officer at Rubedo Life Sciences.
| less than a minute read
Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO
Get in touch
Get in touch
Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells which drive age-related diseases, today announced the appointment of Frederick C. Beddingfield III, M.D., Ph.D., as Chief Executive Officer and board director.
Get in touch
Get in touch
Latest Insights
/Passle/58a5cb8db00e8110e83aa395/MediaLibrary/Images/2026-08-04-15-32-04-091-6a7205f4b4306b41266d92f2.jpg)
